The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Isoptin

120 milligram(s) Film-coated tablet

Mylan IRE Healthcare LimitedPA2010/003/003

Main Information

Trade NameIsoptin
Active SubstancesVERAPAMIL HYDROCHLORIDE
Strength120 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/003/003

Group Information

ATC CodeC08DA Phenylalkylamine derivatives
C08DA01 verapamil

Status

Authorised/WithdrawnAuthorised
Licence Issued01/04/1980
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back